• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用类器官培养系统诱导肝内胆管癌细胞向功能性肝细胞分化。

Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system.

机构信息

Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan.

Division of Gastroenterology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

出版信息

Sci Rep. 2018 Feb 12;8(1):2821. doi: 10.1038/s41598-018-21121-6.

DOI:10.1038/s41598-018-21121-6
PMID:29434290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5809480/
Abstract

Intrahepatic cholangiocarcinoma (IHCC) is a highly aggressive malignancy with a poor prognosis. It is thought to originate from cholangiocytes, which are the component cells of intrahepatic bile ducts. However, as patients with viral hepatitis often develop IHCC, it has been suggested that transformed hepatocytes may play a role in IHCC development. To investigate whether IHCC cells can be converted to functional hepatocytes, we established organoids derived from human IHCC and cultured them under conditions suitable for hepatocyte differentiation. IHCC organoids after hepatocyte differentiation acquired functions of mature hepatocytes such as albumin secretion, bile acid production and increased CYP3A4 activity. Studies using a mouse model of IHCC indicate that Wnt3a derived from macrophages recruited upon inflammation in the liver may promote the malignant transformation of hepatocytes to IHCC cells. The results of the present study support the recently proposed hypothesis that IHCC cells are derived from hepatocytes.

摘要

肝内胆管癌(IHCC)是一种侵袭性很强且预后较差的恶性肿瘤。它被认为起源于胆管细胞,胆管细胞是肝内胆管的组成细胞。然而,由于患有病毒性肝炎的患者常常会发展为 IHCC,因此有人认为转化的肝细胞可能在 IHCC 的发展中发挥作用。为了研究 IHCC 细胞是否可以转化为功能性肝细胞,我们建立了源自人 IHCC 的类器官,并在适合肝细胞分化的条件下对其进行培养。分化后的 IHCC 类器官获得了成熟肝细胞的功能,如白蛋白分泌、胆汁酸生成和 CYP3A4 活性增加。使用 IHCC 小鼠模型的研究表明,炎症时招募到肝脏的巨噬细胞中产生的 Wnt3a 可能促进了肝细胞向 IHCC 细胞的恶性转化。本研究的结果支持了最近提出的假说,即 IHCC 细胞来源于肝细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/87bdeba442d9/41598_2018_21121_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/f198cd00c0f8/41598_2018_21121_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/43505900387d/41598_2018_21121_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/fda3b3d1522f/41598_2018_21121_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/c90035726cc8/41598_2018_21121_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/24f586d09bc9/41598_2018_21121_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/56ef40b0df6b/41598_2018_21121_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/20b29045c5a2/41598_2018_21121_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/87bdeba442d9/41598_2018_21121_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/f198cd00c0f8/41598_2018_21121_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/43505900387d/41598_2018_21121_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/fda3b3d1522f/41598_2018_21121_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/c90035726cc8/41598_2018_21121_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/24f586d09bc9/41598_2018_21121_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/56ef40b0df6b/41598_2018_21121_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/20b29045c5a2/41598_2018_21121_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5809480/87bdeba442d9/41598_2018_21121_Fig8_HTML.jpg

相似文献

1
Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system.利用类器官培养系统诱导肝内胆管癌细胞向功能性肝细胞分化。
Sci Rep. 2018 Feb 12;8(1):2821. doi: 10.1038/s41598-018-21121-6.
2
Preoperatively undiagnosable intrahepatic bile duct dilatation contains early-stage intrahepatic cholangiocarcinoma.术前无法诊断的肝内胆管扩张包含早期肝内胆管癌。
Hepatogastroenterology. 2005 Sep-Oct;52(65):1368-71.
3
Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes.肝内胆管癌可源于 Notch 介导的肝细胞转化。
J Clin Invest. 2012 Nov;122(11):3914-8. doi: 10.1172/JCI63065.
4
Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.肝癌衍生生长因子:肝内胆管癌的一种新型预后生物标志物。
Tumour Biol. 2015 Jan;36(1):353-64. doi: 10.1007/s13277-014-2651-0. Epub 2014 Sep 28.
5
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.突变 IDH 抑制 HNF-4α 以阻断肝细胞分化并促进胆管癌。
Nature. 2014 Sep 4;513(7516):110-4. doi: 10.1038/nature13441. Epub 2014 Jul 2.
6
Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.Notch2 控制小鼠肝细胞源性胆管癌的形成。
Oncogene. 2018 Jun;37(24):3229-3242. doi: 10.1038/s41388-018-0188-1. Epub 2018 Mar 16.
7
Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.表达致癌 KRAS 的类器官具有胆管上皮干细胞特性,可在小鼠中引发胆管癌。
Cancer Sci. 2021 May;112(5):1822-1838. doi: 10.1111/cas.14703. Epub 2021 Mar 8.
8
Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.乙型肝炎病毒相关的肝内胆管癌起源于肝细胞。
Hepatol Int. 2023 Oct;17(5):1300-1317. doi: 10.1007/s12072-023-10556-3. Epub 2023 Jun 27.
9
Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients.初诊时原发性肝内胆管癌CT表现与转移扩散及临床结局的相关性:92例患者的回顾性研究
Abdom Imaging. 2014 Dec;39(6):1193-201. doi: 10.1007/s00261-014-0167-0.
10
Upregulation of long non‑coding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma.长链非编码 RNA CCAT2 的上调表明肝内胆管癌预后不良,并促进其增殖和转移。
Mol Med Rep. 2018 Apr;17(4):5328-5335. doi: 10.3892/mmr.2018.8518. Epub 2018 Jan 30.

引用本文的文献

1
Applications of 3D models in cholangiocarcinoma.3D模型在胆管癌中的应用。
Front Oncol. 2025 Jul 31;15:1598552. doi: 10.3389/fonc.2025.1598552. eCollection 2025.
2
HNF4α inhibits the malignancy of intrahepatic cholangiocarcinoma by suppressing the Wnt signaling pathway.肝细胞核因子4α通过抑制Wnt信号通路来抑制肝内胆管癌的恶性程度。
Transl Oncol. 2025 Mar;53:102290. doi: 10.1016/j.tranon.2025.102290. Epub 2025 Jan 25.
3
State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment.

本文引用的文献

1
Bone marrow-derived macrophages distinct from tissue-resident macrophages play a pivotal role in Concanavalin A-induced murine liver injury via CCR9 axis.与组织驻留巨噬细胞不同的骨髓来源巨噬细胞通过CCR9轴在伴刀豆球蛋白A诱导的小鼠肝损伤中起关键作用。
Sci Rep. 2016 Oct 11;6:35146. doi: 10.1038/srep35146.
2
A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.结直肠肿瘤类器官文库显示肿瘤发生过程中龛位因子需求逐渐丧失。
Cell Stem Cell. 2016 Jun 2;18(6):827-838. doi: 10.1016/j.stem.2016.04.003. Epub 2016 May 19.
3
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes.
前沿肝癌类器官:为个性化治疗模拟癌症干细胞异质性
BioDrugs. 2025 Mar;39(2):237-260. doi: 10.1007/s40259-024-00702-0. Epub 2025 Jan 18.
4
Primary liver cancer organoids and their application to research and therapy.原发性肝癌类器官及其在研究与治疗中的应用。
J Natl Cancer Cent. 2024 Jun 17;4(3):195-202. doi: 10.1016/j.jncc.2024.06.002. eCollection 2024 Sep.
5
Bioengineered Organoids Offer New Possibilities for Liver Cancer Studies: A Review of Key Milestones and Challenges.生物工程类器官为肝癌研究提供新可能:关键里程碑与挑战综述
Bioengineering (Basel). 2024 Apr 1;11(4):346. doi: 10.3390/bioengineering11040346.
6
Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.肝类器官:肿瘤进展和肝癌精准医学中洞察和创新的有前途的三维模型。
Front Immunol. 2023 Jun 2;14:1180184. doi: 10.3389/fimmu.2023.1180184. eCollection 2023.
7
Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma.胆汁代谢物作为肝门部胆管癌的诊断生物标志物。
Sci Rep. 2023 Feb 23;13(1):3177. doi: 10.1038/s41598-023-27603-6.
8
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping.对源自肝内胆管癌类器官的多种基因组数据进行综合分析可实现肿瘤亚型分类。
Nat Commun. 2023 Jan 16;14(1):237. doi: 10.1038/s41467-023-35896-4.
9
Functional Evaluation of 3D Liver Models Labeled with Polysaccharide Functionalized Magnetic Nanoparticles.用多糖功能化磁性纳米颗粒标记的3D肝脏模型的功能评估
Materials (Basel). 2022 Nov 5;15(21):7823. doi: 10.3390/ma15217823.
10
Applications of human organoids in the personalized treatment for digestive diseases.类器官在消化系统疾病个体化治疗中的应用
Signal Transduct Target Ther. 2022 Sep 27;7(1):336. doi: 10.1038/s41392-022-01194-6.
WNT/β-连环蛋白信号通路的阶段特异性调控增强了人胚胎干细胞向肝细胞的分化。
J Hepatol. 2016 Jun;64(6):1315-26. doi: 10.1016/j.jhep.2016.02.028. Epub 2016 Feb 26.
4
Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma.Wnt/β-连环蛋白信号通路在间充质干细胞中的参与促进胆管癌的转移生长和化疗耐药性。
Oncotarget. 2015 Dec 8;6(39):42276-89. doi: 10.18632/oncotarget.5514.
5
Prospective derivation of a living organoid biobank of colorectal cancer patients.前瞻性建立结直肠癌患者活体类器官生物样本库。
Cell. 2015 May 7;161(4):933-45. doi: 10.1016/j.cell.2015.03.053.
6
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited.WNT信号传导驱动胆管癌生长,并且可以被药物抑制。
J Clin Invest. 2015 Mar 2;125(3):1269-85. doi: 10.1172/JCI76452. Epub 2015 Feb 17.
7
Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages.炎症中巨噬细胞的个体发生与极化:血液单核细胞与组织巨噬细胞
Front Immunol. 2015 Jan 22;5:683. doi: 10.3389/fimmu.2014.00683. eCollection 2014.
8
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity.具有胆管表型的肝癌的全基因组突变景观揭示了肝炎的影响和分子多样性。
Nat Commun. 2015 Jan 30;6:6120. doi: 10.1038/ncomms7120.
9
Organoid models of human and mouse ductal pancreatic cancer.人类和小鼠胰腺导管癌的类器官模型
Cell. 2015 Jan 15;160(1-2):324-38. doi: 10.1016/j.cell.2014.12.021. Epub 2014 Dec 31.
10
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.胆管癌的突变谱分析:预后及治疗意义
PLoS One. 2014 Dec 23;9(12):e115383. doi: 10.1371/journal.pone.0115383. eCollection 2014.